Crystallographic and functional studies of a modified form of eosinophil-derived neurotoxin (EDN) with novel biological activities

J Mol Biol. 2002 Mar 15;317(1):119-30. doi: 10.1006/jmbi.2002.5406.

Abstract

The crystal structure of a post-translationally modified form of eosinophil-derived neurotoxin (EDN) with four extra residues on its N terminus ((-4)EDN) has been solved and refined at atomic resolution (1 A). Two of the extra residues can be placed unambiguously, while the density corresponding to two others is poor. The modified N terminus appears to influence the position of the catalytically important His129, possibly explaining the diminished catalytic activity of this variant. However, (-4)EDN has been shown to be cytotoxic to a Kaposi's sarcoma tumor cell line and other endothelial cell lines. Analysis of the structure and function suggests that the reason for cytotoxicity is most likely due to cellular recognition by the N-terminal extension, since the intrinsic activity of the enzyme is not sufficient for cytotoxicity and the N-terminal extension does not affect the conformation of EDN.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Binding Sites
  • Cattle
  • Crystallography, X-Ray
  • Endothelium / drug effects
  • Endothelium / metabolism
  • Endothelium / pathology
  • Eosinophil-Derived Neurotoxin
  • Fluorescent Antibody Technique
  • Humans
  • Models, Molecular
  • Protein Binding
  • Protein Processing, Post-Translational
  • Protein Structure, Secondary
  • Ribonuclease, Pancreatic / chemistry
  • Ribonucleases / chemistry*
  • Ribonucleases / genetics
  • Ribonucleases / metabolism*
  • Ribonucleases / pharmacology
  • Sarcoma, Kaposi / metabolism
  • Sarcoma, Kaposi / pathology
  • Structure-Activity Relationship
  • Tumor Cells, Cultured

Substances

  • Eosinophil-Derived Neurotoxin
  • Ribonucleases
  • Ribonuclease, Pancreatic
  • ranpirnase

Associated data

  • PDB/1K2A